Related Experiment Video
Updated: Apr 20, 2026
In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
[Cancer and inflammation: differentiation by USPIO-enhanced MR imaging]
Purpose:
To assess ultrasmall superparamagnetic iron oxide particles (USPIO) -enhanced MR imaging for the differentiation of malignant from benign, inflammatory lesions.
Materials And Methods:
In this study, approved by the local animal care committee, VX2 carcinoma and intramuscular abscesses were implanted into the hind thighs of New Zealand White rabbits. MR imaging was performed pre contrast and serially for 24 h after the injection of USPIO. MR findings were compared with histopathologic results based on Prussian blue stains for the presence of iron.
Results:
Twenty-four hours after the Ferumoxtran-injection, no changes were observed in VX2 carcinomas, whereas a mean reduction of the contrast-to-noise ratio (CNR) of approximately 90 % was noticed in abscesses as well as in necrotic tumors. On histopathologic examination, abscess and necrotic parts of the tumor were found to include iron-containing monocytes demonstrating that the reduction in CNR was caused by USPIO-tagged monocytes.
Conclusion:
Our results prove the ability of USPIO-enhanced MRI to differentiate benign, inflammatory from malignant lesions.
Insights
Ultrasmall superparamagnetic iron oxide particles (USPIO) -enhanced MRI can differentiate benign inflammatory lesions from malignant ones. USPIO-enhanced MRI effectively distinguishes between these conditions in preclinical models.
Area of Science:
- Biomedical Imaging
- Magnetic Resonance Imaging
- Nanotechnology in Medicine
Background:
- Distinguishing malignant from benign lesions is crucial in clinical diagnosis.
- Superparamagnetic iron oxide nanoparticles offer potential contrast enhancement in MRI.
- Ultrasmall superparamagnetic iron oxide particles (USPIO) are a class of nanoparticles with specific imaging properties.
Purpose of the Study:
- To evaluate the efficacy of ultrasmall superparamagnetic iron oxide particles (USPIO) -enhanced MRI for differentiating malignant from benign, inflammatory lesions.
- To assess the diagnostic performance of USPIO-enhanced MRI in a preclinical model.
Main Methods:
- VX2 carcinoma and abscess models were established in rabbit hind thighs.
- Magnetic resonance imaging (MRI) was performed before and after USPIO injection.
- MR findings were correlated with histopathologic analysis using Prussian blue staining for iron.
Main Results:
- A significant reduction in contrast-to-noise ratio (CNR) of approximately 90% was observed in abscesses and necrotic tumors 24 hours post-USPIO injection.
- No significant changes in CNR were noted in viable VX2 carcinomas.
- Histopathology confirmed the presence of iron-containing monocytes in abscesses and necrotic tumor areas, explaining the CNR reduction.
Conclusions:
- USPIO-enhanced MRI demonstrated the ability to differentiate benign inflammatory lesions from malignant ones.
- The uptake of USPIO by monocytes plays a key role in the observed contrast changes.
- This technique shows promise for improving lesion characterization in medical imaging.
